Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) Diet in Stroke Patients Patients
Running, not enrolling · Not applicable
Conditions studied: Cognitive Decline, Dementia, Vascular, Alzheimer Disease, Dementia, Stroke
In brief
To test the effects of a 2- to 3-year intervention of the MIND diet versus usual post-stroke care on cognitive decline, the characteristic feature of dementia, and on brain biomarkers of Alzheimer's Disease (AD) and vascular disease in a Phase Ill randomized controlled trial of 250 patients hospitalized for acute ischemic stroke, aged 55 years or older, and without dementia who are discharged home following hospitalization.
Key facts
- Study ID
- NCT04337255
- Run by
- Rush University Medical Center
- People needed
- 250
- Starts
- 2021-12-14
- Expected to finish
- 2026-07-31
- Last updated by the study team
- 2026-04-21
Who can join
Age: 55 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Rush University Medical Center — Chicago, Illinois, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.